Please note that, at the request of stakeholders, the deadline for the following CADTH calls for stakeholder input has been extended to November 9, 2015 at 5:00 p.m. EST:
CDR Update – Issue 111:
Consultation regarding the deadline for voluntary withdrawals of CDR submissions and resubmissions
Consultation regarding the sharing of CADTH reviewe...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
Call for Feedback Deadline: November 9, 2015 at 5:00 p.m. ET via email to email@example.com.
CADTH is inviting stakeholder comments and feedback on the proposed framework to align drug expert committee recommendations to be used in both the CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) programs.
Background and Cont...
Today CADTH posted our Guidance Document on Reporting Indirect Comparisons
Indirect comparison methodology allows for the comparison of treatments that have not been directly compared in head-to-head trials. Indirect comparisons are increasingly common, but reporting often lacks an adequate description of the methodology used.
This CADTH guidanc...
CADTH is hosting a series of lectures by prominent scholars and opinion leaders to share their perspectives on some of the most pressing issues facing health technology assessment (HTA) and health care today.
We invite you to attend the next lecture which is being presented in partnership with the Canadian Foundation for Healthcare Improvement (...